LeonaBio clinical trials we track

Check company identity source

Phase 3 1 trial

Phase 2 / 3 2 trials

TrialDrugs studiedStatusPrimary completion
ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04488419ATH-1017Completed2024-07-15Actual
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04886063ATH-1017Terminated2024-10-23Actual

Phase 2 2 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters